What is T-62 used for?

T-62 is being studied as a potential treatment for postherpetic neuralgia, which is the nerve pain that can occur after someone has had shingles.

Is T-62 approved by the FDA?

No, T-62 is currently a research compound in clinical development and is not yet an approved drug.

What stage of testing is T-62 in?

T-62 is currently in Phase 2 of clinical research.

What kind of drug is T-62?

T-62 is classified as a small molecule drug.

Does T-62 have known side effects?

There is currently no specific information provided regarding the side effects of T-62 in the available data.

Can T-62 treat shingles pain?

It is being investigated for postherpetic neuralgia, which is the pain that stays in the nerves after a shingles infection has cleared.

NS00068295 | CAS 40312-34-3 | OTZVBZFYMFTYKH

Loading compound...

Small molecule research compound

T-62 is a small molecule drug currently being studied in clinical research. It is being investigated for its potential to treat postherpetic neuralgia, which is nerve pain that follows a shingles outbreak.

How it worksThe specific way T-62 works in the body is not fully detailed in the available research data.

Used for

postherpetic neuralgia (nerve pain after shingles)

Conditions

postherpetic neuralgia

Class

Small moleculeSmall molecule research compound

How to take

This compound is currently in the research phase (Max Phase 2) and is not an FDA-approved medication for general use.

Talk to your doctor

Questions to ask

·Is T-62 being used in any clinical trials for nerve pain?
·What are the potential risks of T-62 during clinical testing?

Educational summary derived from FDA labeling, AI-assisted. Not medical advice — consult a healthcare professional. Updated 2026-04-26.

How to take

Talk to your doctor

Frequently asked questions (6)